» Articles » PMID: 34071605

Regulation of Bone Cell Differentiation and Activation by Microbe-Associated Molecular Patterns

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jun 2
PMID 34071605
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Gut microbiota has emerged as an important regulator of bone homeostasis. In particular, the modulation of innate immunity and bone homeostasis is mediated through the interaction between microbe-associated molecular patterns (MAMPs) and the host pattern recognition receptors including Toll-like receptors and nucleotide-binding oligomerization domains. Pathogenic bacteria such as and tend to induce bone destruction and cause various inflammatory bone diseases including periodontal diseases, osteomyelitis, and septic arthritis. On the other hand, probiotic bacteria such as and species can prevent bone loss. In addition, bacterial metabolites and various secretory molecules such as short chain fatty acids and cyclic nucleotides can also affect bone homeostasis. This review focuses on the regulation of osteoclast and osteoblast by MAMPs including cell wall components and secretory microbial molecules under in vitro and in vivo conditions. MAMPs could be used as potential molecular targets for treating bone-related diseases such as osteoporosis and periodontal diseases.

Citing Articles

Advancements in GelMA bioactive hydrogels: Strategies for infection control and bone tissue regeneration.

Huang L, Guo Z, Yang X, Zhang Y, Liang Y, Chen X Theranostics. 2025; 15(2):460-493.

PMID: 39744697 PMC: 11671377. DOI: 10.7150/thno.103725.


Dietary Effects of Probiotic Bacteria, AV5 on Growth, Serum and Mucus Immune Response, Metabolomics, and Lipid Metabolism in Nile Tilapia ().

Shija V, Zakaria G, Amoah K, Yi L, Huang J, Masanja F Aquac Nutr. 2024; 2024:4253969.

PMID: 39555520 PMC: 11333138. DOI: 10.1155/2024/4253969.


Inducing cyclooxygenase-2 expression, prostaglandin E and prostaglandin F production of human dental pulp cells by activation of toll-like receptor-3, mitogen-activated protein kinase kinase/extracellular signal-regulated kinase and p38 signaling.

Chang M, Wu J, Chen S, Hsu Y, Yeung S, Pan Y J Dent Sci. 2024; 19(2):1190-1199.

PMID: 38618082 PMC: 11010691. DOI: 10.1016/j.jds.2023.11.009.


IL-23/IL-17 axis levels in gingival crevicular fluid of subjects with periodontal disease: a systematic review.

Alarcon-Sanchez M, Guerrero-Velazquez C, Becerra-Ruiz J, Rodriguez-Montano R, Avetisyan A, Heboyan A BMC Oral Health. 2024; 24(1):302.

PMID: 38431633 PMC: 10909298. DOI: 10.1186/s12903-024-04077-0.


Repair of Infected Bone Defects with Hydrogel Materials.

Cao Z, Qin Z, Duns G, Huang Z, Chen Y, Wang S Polymers (Basel). 2024; 16(2).

PMID: 38276689 PMC: 10820481. DOI: 10.3390/polym16020281.


References
1.
Chen M, Chang C, Hu C, Wu Y, Chang Y, Ueng S . Periprosthetic Joint Infection Caused by Gram-Positive Versus Gram-Negative Bacteria: Lipopolysaccharide, but not Lipoteichoic Acid, Exerts Adverse Osteoclast-Mediated Effects on the Bone. J Clin Med. 2019; 8(9). PMC: 6780630. DOI: 10.3390/jcm8091289. View

2.
Kadono H, Kido J, Kataoka M, Yamauchi N, Nagata T . Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis. Infect Immun. 1999; 67(6):2841-6. PMC: 96590. DOI: 10.1128/IAI.67.6.2841-2846.1999. View

3.
Schepper J, Collins F, Rios-Arce N, Raehtz S, Schaefer L, Gardinier J . Probiotic Lactobacillus reuteri Prevents Postantibiotic Bone Loss by Reducing Intestinal Dysbiosis and Preventing Barrier Disruption. J Bone Miner Res. 2019; 34(4):681-698. PMC: 6557403. DOI: 10.1002/jbmr.3635. View

4.
Binder Gallimidi A, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein A . Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget. 2015; 6(26):22613-23. PMC: 4673186. DOI: 10.18632/oncotarget.4209. View

5.
Wang S, Heng B, Qiu S, Deng J, Pan Cheung G, Jin L . Lipoteichoic acid of Enterococcus faecalis inhibits osteoclastogenesis via transcription factor RBP-J. Innate Immun. 2018; 25(1):13-21. PMC: 6830893. DOI: 10.1177/1753425918812646. View